The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
Abstract
Cyclophosphamide-induced lung toxicity may be difficult to recognize because of the presence of confounding variables such as concomitant use of other cytotoxic drugs, opportunistic infections, diffuse pulmonary malignancy, radiation pneumonitis, and oxygen toxicity. The purpose of this retrospective analysis was to identify the clinical spectrum of pulmonary toxicity of cyclophosphamide. In our review of case records, we sought to identify patients in whom cyclophosphamide was the only identifiable etiologic factor for lung toxicity. In a 20-yr period six patients were identified with cyclophosphamide-induced lung disease, including five men and one woman ranging in age from 42 to 78 yr. Clinical features of toxicity include dyspnea, fever, cough, new parenchymal infiltrates, gas exchange abnormalities on pulmonary function tests, and pleural thickening on chest roentgenogram. Two patterns of cyclophosphamide-induced lung toxicity were identified. A single patient presented with early-onset pneumonitis and responded to discontinuation of the drug. Five patients with late-onset pneumonitis developed progressive pulmonary fibrosis associated with bilateral pleural thickening. Patients with late-onset pneumonitis showed no response to cessation of cyclophosphamide and institution of corticosteroid therapy. Three of these patients died of respiratory failure. Careful review of the individual cases reported in the literature as cyclophosphamide lung toxicity revealed only 12 cases in whom none of the additional confounding factors could be identified. These could easily be divided in the same two categories. Early-onset pneumonitis is reversible and may respond to corticosteroid therapy. Late-onset pneumonitis, frequently associated with pleural thickening, is clinically distinct from idiopathic pulmonary fibrosis but has a chronically progressive course. It appears unresponsive to corticosteroid therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nishino, H., Rubino, F. A., DeRemee, R. A., Swanson, J. W., & Parisi, J. E. (1993) · Annals of Neurology · doi:10.1002/ana.410330103 · Cited by 544
Self-citationThe pulmonary toxicity of antineoplastic agents.
Ginsberg, S. J., & Comis, R. L. (1982) · PubMed · Cited by 235
Cyclophosphamide therapy and interstitial pulmonary fibrosis
Patel, A. R., Shah, P. C., Rhee, H. L., Sassoon, H., & Rao, K. P. (1976) · Cancer · Cited by 128
Drug-induced pulmonary disease
Rosenow, E. C. (1994) · Disease-a-Month · doi:10.1016/0011-5029(94)90025-6 · Cited by 122
Cited by
Pulmonary Drug Toxicity: Radiologic and Pathologic Manifestations
Rossi, S. E., Erasmus, J. J., McAdams, H. P., Sporn, T. A., & Goodman, P. C. (2000) · RadioGraphics · doi:10.1148/radiographics.20.5.g00se081245 · Cited by 449
Solomon, J. J., Olson, A. L., Fischer, A., Bull, T., Brown, K. K., & Raghu, G. (2013) · European Respiratory Review · doi:10.1183/09059180.00005512 · Cited by 294
DOUGLAS, W. W., RYU, J. H., SWENSEN, S. J., OFFORD, K. P., SCHROEDER, D. R., CARON, G. M., & DeREMEE, R. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.1.9709089 · Cited by 182
Self-citation
Metadata
- Authors
- Malik, S. W., Myers, J. L., DeRemee, R. A., & Specks, U.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-12
- Volume
- 154
- Issue
- 6
- Pages
- 1851-1856
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2088651599
- Cited by
- 274
- References
- 4
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lung toxicity associated with cyclophosphamide use. Two distinct patterns. https://app.cochat.ai/papers/10.1164/ajrccm.154.6.8970380
- The paper
- Malik, S. W., Myers, J. L., DeRemee, R. A., & Specks, U. (1996). Lung toxicity associated with cyclophosphamide use. Two distinct patterns. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/ajrccm.154.6.8970380
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.